Discovery of Dual-Degrading Compound Could Pave Way for More Effective Cancer Drugs
University of Florida researchers have developed a new compound that simultaneously attacks two key proteins critical for a cancer cell’s survival, a discovery that could aid in the development of more effective leukemia, lung and colon cancer drugs.
UF Anticancer Drug Receives FDA Clearance for Clinical Trials
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
